Forbes

Forbes 30 Under 30 2017: Science

Mark Smith, 29
Cofounder, OpenBiome

Smith's company, OpenBiome, developed a therapy called fecal microbiota transplantation to treat Clostridium difficile, a common hospital-acquired infection. Like a blood bank for human stool, the nonprofit's work has helped over 18,000 patients. 

Click here for the full profile.

Stool Transplants Save Lives. Why Don't We Use Them Early For Deadly C. Diff?

There is better efficacy data for FMT treatment than for many things that we do to our patients. Isn’t it time that we got over our juvenile squeamishness and offered our patients life-saving stool transplants initially, without cumbersome barriers? This treatment appears more efficacious and is almost certainly cost-effective as well. It’s time for widespread adaptation of this technique, including in those who are acutely ill.

Click here for the full article.